GE Healthcare Joins Personalized Medicine Fray, Seeks Drug Firm Alliances
This article was originally published in The Gray Sheet
Executive Summary
GE Healthcare's pursuit of personalized medicine through the April 8 integration of Amersham likely will involve co-development agreements with large pharmaceutical firms